We showed that inhibition of XPO1 by small interfering RNAs (siRNAs) or with a XPO1 inhibitor, KPT-8602, blocked cell proliferation and growth transformation by inducing p53-mediated cell cycle arrest in all types of cancer cells tested. This evidence concerns the gene TP53 and cancer.